Citadel Advisors
ALXN

Citadel Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,248,848
Closed -$597M 7637
2021
Q2
$597M Buy
3,248,848
+745,676
+30% +$137M 0.13% 4
2021
Q1
$383M Buy
2,503,172
+1,675,222
+202% +$256M 0.09% 22
2020
Q4
$129M Buy
827,950
+286,243
+53% +$44.7M 0.03% 152
2020
Q3
$62M Sell
541,707
-587,984
-52% -$67.3M 0.02% 316
2020
Q2
$127M Sell
1,129,691
-1,746,572
-61% -$196M 0.05% 121
2020
Q1
$258M Buy
2,876,263
+2,806,057
+3,997% +$252M 0.12% 30
2019
Q4
$7.59M Sell
70,206
-16,889
-19% -$1.83M ﹤0.01% 1343
2019
Q3
$8.53M Sell
87,095
-117,979
-58% -$11.6M ﹤0.01% 1298
2019
Q2
$26.9M Buy
205,074
+134,585
+191% +$17.6M 0.01% 650
2019
Q1
$9.53M Sell
70,489
-372,439
-84% -$50.3M ﹤0.01% 1156
2018
Q4
$43.1M Sell
442,928
-907,169
-67% -$88.3M 0.02% 369
2018
Q3
$188M Sell
1,350,097
-378,393
-22% -$52.6M 0.08% 93
2018
Q2
$215M Buy
1,728,490
+1,034,537
+149% +$128M 0.11% 71
2018
Q1
$77.3M Sell
693,953
-1,292,263
-65% -$144M 0.04% 211
2017
Q4
$238M Buy
1,986,216
+1,254,689
+172% +$150M 0.14% 61
2017
Q3
$103M Sell
731,527
-385,221
-34% -$54M 0.08% 145
2017
Q2
$136M Buy
1,116,748
+1,012,751
+974% +$123M 0.12% 88
2017
Q1
$12.6M Buy
103,997
+78,149
+302% +$9.47M 0.01% 788
2016
Q4
$3.16M Sell
25,848
-191,481
-88% -$23.4M ﹤0.01% 1269
2016
Q3
$26.6M Sell
217,329
-1,186,651
-85% -$145M 0.03% 411
2016
Q2
$164M Buy
1,403,980
+1,349,404
+2,473% +$158M 0.18% 39
2016
Q1
$7.6M Buy
54,576
+45,839
+525% +$6.38M 0.01% 818
2015
Q4
$1.67M Sell
8,737
-64,096
-88% -$12.2M ﹤0.01% 1675
2015
Q3
$11.4M Sell
72,833
-342,262
-82% -$53.5M 0.01% 858
2015
Q2
$75M Sell
415,095
-726,759
-64% -$131M 0.07% 259
2015
Q1
$198M Buy
1,141,854
+892,456
+358% +$155M 0.19% 55
2014
Q4
$46.1M Sell
249,398
-51,159
-17% -$9.47M 0.05% 376
2014
Q3
$49.8M Sell
300,557
-249,310
-45% -$41.3M 0.05% 296
2014
Q2
$85.9M Buy
549,867
+103,142
+23% +$16.1M 0.1% 162
2014
Q1
$68M Buy
446,725
+206,800
+86% +$31.5M 0.08% 210
2013
Q4
$31.9M Sell
239,925
-1,268,531
-84% -$169M 0.04% 400
2013
Q3
$175M Buy
1,508,456
+545,684
+57% +$63.4M 0.27% 34
2013
Q2
$88.8M Buy
+962,772
New +$88.8M 0.15% 108